The Ramboll Health Sciences team: Naomi Young, Thomas Sendor, Ana I. Sánchez, Ilona Hanke and our new colleagues Cathrin Weimann, Henry von Rège and Marta Borges Ordono from SCC – Scientific Consulting Company – will be attending the event.
With global reach and local expertise, we help navigate the complexity of current biocide/antimicrobial regulation. From substance, family and product development to post-market stewardship and treated articles, we support you throughout the product lifecycle with strategic and technical services, optimising competitive advantage and reducing liability.
- Horizon scanning for any future substance concerns
- Management of active substance consortia as technical consultant and consortium manager
- Handling submissions for national authorisation, mutual recognition, union authorisation, authorisation of same biocidal products and simplified authorisation
- Socio-economic cases/comparative assessment of alternatives
- Support on nanoforms
- EU BPR, GB BPR, K-BPR and global approvals eg USA FIFRA
- Help develop robust route-to-market and product stewardship strategies
- Monitoring, analysis, design, placement and evaluation of studies for active substances, products and families
- Regulatory engagement and presentations. A strategic partner for representing our clients’ interests before national authorities, the European Commission and ECHA
- Risk assessments for human health and environment, including eg
- ED assessment and mechanistic evaluations
- In silico QSAR assessments eg for impurity or metabolite profiling
- NAMs
- Technical safety data and biocidal claim support
- Preparation, submission and defence of dossiers for more than 70 active substance/PT combinations (initial approval) and involved in several recent renewal applications